Classification and therapy of atrophie blanche
- 1 December 1983
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 119 (12) , 963-969
- https://doi.org/10.1001/archderm.119.12.963
Abstract
Atrophie blanche usually appears as painful purpuric papules that evolve into ulcerations and, finally, angular scars on the lower extremities. The literature on this subject presents a confusing picture of its causes, pathogenesis, and treatment. Atrophie blanche is best categorized as a clinicopathologic entity with multiple causes. Its characteristic histopathologic features and clinical evolution indicate that the common pathologic event is occlusion of vessels in the middle and deep dermis. No single form of therapy was consistently effective for the treatment of atrophie blanche, but drugs that inhibit platelet thrombus formation or stimulate endogenous fibrinolytic activity arrest the disease in most patients.This publication has 4 references indexed in Scilit:
- Antiplatelet therapy in atrophie blanche and livedo vasculitisJournal of the American Academy of Dermatology, 1982
- Atrophie blanche. A sign of dermal blood occlusionArchives of Dermatology, 1974
- Atrophie blanche: periodic painful ulcers of lower extremities. A clinical and histopathological entityArchives of Dermatology, 1966
- Livedo Reticularis with UlcerationsCirculation, 1956